This page contains content forconsumers. Do you want to continue?
Improved sequencing success begins with reliably effective solutions
Our innovative and automation-friendly workflow with our new KAPA Target Enrichment products is compatible with a variety of sample inputs, able to free-up time and resources to give you greater peace of mind
Next-generation sequencing (NGS) is driving advances in translational and clinical research. From expanding our understanding of cancer, reproductive and developmental biology to unravelling complex microbial populations, NGS is touching all facets of human disease and wellbeing.
Sample prep for next generation sequencing holds the key to unlocking the potential of every sample. Explore our integrated Roche Sample Preparation Solutions, encompassing all the steps required to convert a sample to a sequencing-ready library. From sample collection to library quantification, we offer sample prep solutions for different sample types and sequencing applications that are proven, simple and complete.
Battling COVID-19 through NGS Analysis of Viral Isolates
Genetic analysis of viral isolates in COVID-19 patients can help follow transmission routes, new strains, and drug resistance. See how scientists can use this information for developing more reliable diagnostics and treatments.
Cancer Personalized Profiling by Deep Sequencing (CAPP-Seq)
Using hybridization capture based target enrichment, CAPP-Seq is a robust solution that can be used for multiple applications including precision-based detection of cancer recurrence and genetically-targeted selection of personalized cancer therapy.